Skip to main content
AppaltiWatch

FORNITURA DI FARMACO ORKAMBI (LUMACAFTOR / IVACAFTOR) AD USO PEDIATRICO. PROCEDURA NEGOZIATA AI SENSI DELL'ART. 63, COMMA 2, LETTERA B) D.LGS 50/2016, NELLE MORE DELL'ATTIVAZIONE DI NUOVE CONVENZIONI ARCA. DITTA VERTEX PHARMACEUTICALS.

AZIENDA SOCIO SANITARIA TERRITORIALE DELLA FRANCIACORTA

CIG 78741691D2Verify on ANACLombardy · ChiariGoods / suppliesCompetitive dialogueCPV 33690000-3Risk signal — not an accusation of crime.
At a glance
Key figures from open ANAC records for this contract.

Amount

€168,922

Award date

7 May 2019

Bids

1

Published

15 Apr 2019

Estimated tender value

€168,922

Sector (CPV)

MEDICINALI VARI
Timeline

  1. Publication / start of procedure

    15 Apr 2019

    Step completed

  2. Time to submit bids

    19 Apr 2019

    4 days between opening and deadline

    Step completed

  3. Award

    7 May 2019

In plain language

These are automated checks on public data. They help you decide what to look into — they are not criminal findings.

This contract triggered 4 pattern(s) worth a closer look:

Low competition · Tight deadlines

Contracting authority (buyer)
AZIENDA SOCIO SANITARIA TERRITORIALE DELLA FRANCIACORTA

Lombardy · More tenders in this area

AUSA code: 0000546278

CHIARI

Authority profile
Awarded to (suppliers)
1 award line(s) on record.
SupplierRegionAmountAward dateStatus
VERTEX PHARMACEUTICALS (ITALY) S.R.L.—€168,9227 May 2019AGGIUDICATA
How do I verify this tender?

Loading actions…

Similar tenders in the same area

Loading comparison…

Sector comparison

Loading…

Amount vs category

Loading…

Citizen verifier notes
Share what you verified on official sources — not a verdict
How the score is built
Ruleset 2.0.0 · 5 Jul 2026
Source data & verification

ANAC BDNCP — dati tabellari

Verify on ANAC

Ingested: 28 Jun 2026

Release: 20260601-cig_csv.csv

Days to submit bids: 4

FORNITURA DI FARMACO ORKAMBI (LUMACAFTOR / IVACAFTOR) AD USO PEDIATRICO. PROCEDURA NEGOZIATA AI SENSI DELL'ART. 63, COMMA 2, LETTERA B) D.LGS 50/2016, NELLE MORE DELL'ATTIVAZIONE DI NUOVE CONVENZIONI ARCA. DITTA VERTEX PHARMACEUTICALS. — AppaltiWatch